Holen Sie sich die Stockscreener-App
2.75
1.79%
-0.05
Handel nachbörslich:
2.71
-0.04
-1.45%
Equillium Inc Aktie (EQ) Neueste Nachrichten
Equillium Inc. (EQ) Holds Steady at $2.81 – Key Support and Resistance Levels in FocusSystematic Flow - newsline.com
Analysts Grow More Confident In Equillium’s (EQ) Lead Asset EQ504 - Insider Monkey
EQ Q1 2026 Earnings: Wider-than-Expected Loss Weighs on SharesRevenue Miss Report - newsline.com
Equillium COO Christine Zedelmayer sells $42,736 in stock - Investing.com UK
Insider Sell: Stephen Connelly Sells 230,975 Shares of Equillium Inc (EQ) - GuruFocus
Equillium COO Christine Zedelmayer sells $42,736 in stock By Investing.com - Investing.com Nigeria
Equillium (NASDAQ: EQ) Form 144: insider resale activity, 200,000-share sale noted - Stock Titan
Equillium Insider Sold Shares Worth $723,830, According to a Recent SEC Filing - marketscreener.com
Equillium (EQ) COO sells 14,584 shares after exercising stock options - Stock Titan
Equillium (NASDAQ: EQ) CSO Stephen Connelly sells 230,975 shares in open market - Stock Titan
[144] Equillium, Inc. SEC Filing - Stock Titan
Equillium, Inc. (EQ) Discusses Mechanistic Insights Linking AhR Signaling and miR-124 in Inflammatory DiseaseSlideshow (NASDAQ:EQ) 2026-06-03 - Seeking Alpha
Equillium(EQ) Stock Options Chain | Quotes & News - Moomoo
Equillium Reports Inducement Grants under Nasdaq Listing Rule 5635(4) - marketscreener.com
EQ Reiterated by Roth Capital -- Price Target Maintained at $12 - GuruFocus
B. Riley Securities Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Equillium links AhR activation to miR-124 as EQ504 heads toward Phase 1 - MSN
Is Equillium's AhR/miR-124 Axis the Key to Unlocking Inflammatory Disease Treatment - Kavout
Equillium Insider Sold Shares Worth $267,209, According to a Recent SEC Filing - Moomoo
Leerink Partners upgrades Equillium (EQ) - MSN
Equillium principal accounting officer Tom Penny sells $191,750 in stock By Investing.com - Investing.com Nigeria
Equillium sr. vp and coo Christine Zedelmayer sells $267,209 in shares - Investing.com Nigeria
Equillium principal accounting officer Tom Penny sells $191,750 in stock - Investing.com
Equillium sr. vp and coo Christine Zedelmayer sells $267,209 in shares By Investing.com - Investing.com South Africa
Equillium (EQ) accounting officer sells 65,000 shares under 10b5-1 plan - Stock Titan
Equillium (EQ) director receives 70,000 options at $2.84 exercise price - Stock Titan
Equillium (EQ) director receives grant of 70,000 stock options at $2.84 - Stock Titan
[Form 4] Equillium, Inc. Insider Trading Activity - Stock Titan
Equillium (EQ) COO exercises options and sells 95,833 common shares - Stock Titan
Equillium (EQ) grants director 70,000 options vesting over a year - Stock Titan
Equillium (EQ) director Barbara Troupin receives grant of 70,000 stock options - Stock Titan
Equillium Shareholders Approve Reverse Split and Capital Changes - TipRanks
[8-K] Equillium, Inc. Reports Material Event - Stock Titan
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1 - Barchart.com
A Quick Look at Today's Ratings for Equillium(EQ.US), With a Forecast Between $5 to $12 - Moomoo
Leerink upgrades Equillium stock rating on IBD drug potential - Investing.com UK
Equillium Inc. (EQ) Surges 7.98%: Analyzing the Move and Key Technical LevelsAD Line Divergence - The Legal Advocate
EQ Upgraded by Leerink Partners -- Price Target Raised to $6.00 - GuruFocus
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewswire
Equillium Raised to Outperform From Market Perform by Leerink Partners - Moomoo
Stifel reiterates Equillium stock rating on AhR biology data - Investing.com UK
Equillium (EQ) Upgraded to Outperform with Target Price Raised t - GuruFocus
Stifel reiterates Equillium stock rating on AhR biology data By Investing.com - Investing.com Nigeria
1.27%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):